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Abstract
Objective
To perform a systematic review and meta-analysis on the prevalence of sleep-disordered
breathing (SDB) after stroke.
Methods
We searched PubMed, Embase (Ovid), the Cochrane Library, and CINAHL (from their
commencements to April 7, 2017) for clinical studies reporting prevalence and/or severity of
SDB after stroke or TIA. Only sleep apnea tests performed with full polysomnography and
diagnostic devices of the American Academy of Sleep Medicine categories I–IV were included.
We conducted random-effects meta-analysis. PROSPERO registration number:
CRD42017072339.
Results
The initial search identified 5,211 publications. Eighty-nine studies (including 7,096 patients)
met inclusion criteria. Fifty-four studies were performed in the acute phase after stroke (after
less than 1 month), 23 studies in the subacute phase (after 1–3 months), and 12 studies in the
chronic phase (after more than 3 months). Mean apnea-hypopnea index was 26.0/h (SD
21.7–31.2). Prevalence of SDB with apnea-hypopnea index greater than 5/h and greater than
30/h was found in 71% (95% confidence interval 66.6%–74.8%) and 30% (95% confidence
interval 24.4%–35.5%) of patients, respectively. Severity and prevalence of SDB were similar in
all examined phases after stroke, irrespective of the type of sleep apnea test performed. Het-
erogeneity between studies (I2) was mostly high.
Conclusion
The high prevalence of SDB after stroke and TIA, which persists over time, is important in light
of recent studies reporting the (1) feasibility and (2) efficacy of SDB treatment in this clinical
setting.
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Increasing evidence demonstrates a consistent association
between sleep-disordered breathing (SDB) and vascular
morbidity and mortality.1–3 Besides being associated with
cardiovascular risk factors, SDB independently increases the
risk of stroke in the general population and is associated
with other risk factors such as hypertension and atrial
fibrillation.4–6 Furthermore, stroke patients with SDB seem to
bemore prone to early neurologic worsening,7 longer hospital
stays,8 and worse cognitive and functional recovery compared
to stroke patients without SDB.9,10 The prevalence of SDB is
high in patients with stroke and TIA and was found to be 72%
for an apnea-hypopnea index (AHI) of greater than 5/h in
a meta-analysis published in 2010.11 Existing randomized
controlled trials indicate that continuous positive airway
pressure may have a positive effect on neurologic recovery,
especially in the first week after stroke.12
Consequently, in 2014, the American Heart Association/
American Stroke Association stroke guidelines included for
the first time the recommendation for sleep apnea screening
in patients with ischemic stroke or TIA (recommendation
Class IIb, level of evidence B).13 Performing routine poly-
somnographies in patients with acute stroke is difficult be-
cause of availability and environmental circumstances.
Outpatient waiting lists for polysomnographies in the chronic
stroke phase are also causing diagnostic delays. In the last
decade, the use of limited-channel sleep apnea tests has fa-
cilitated SDB diagnosis in patients with stroke. Thus, more
studies have been performed in this field. In this meta-analysis,
we provide an update on prevalence and severity of SDB after
stroke and TIA at different diagnostic time points and using
different types of sleep apnea tests.
Methods
This meta-analysis is reported according to the general
guidelines outlined in the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) state-
ment.14 The study protocol has been registered on PROS-
PERO (crd.york.ac.uk/PROSPERO/; registration number
CRD42017072339).
Search strategy
We systematically searched PubMed, Embase, the Cochrane
Library, and CINAHL (Cumulative Index to Nursing and
Allied Health Literature) from their respective inceptions to
April 2017 for studies assessing the prevalence and severity of
SDB in persons after hemorrhagic stroke, ischemic stroke, or
TIA. We searched free text words and medical subject head-
ings. Terms describing the study population were combined
with specific terms for SDB. Details on the search strategy and
platforms can be found in data available from Dryad (ap-
pendix e-1, doi.org/10.5061/dryad.n76v191). To identify
additional trials, we searched the World Health Organization
International Clinical Trials Registry Platform and Clin-
icalTrials.gov. We also screened the reference lists of included
articles to find additional studies relevant to this review.
Study selection
Study selection was performed independently by 2 reviewers
(L.K., M.C.) who initially identified studies for full-text review
based on titles and abstracts. Then the eligible articles were
selected based on predefined inclusion and exclusion criteria
(see the table for a full list of inclusion and exclusion criteria).
In short, we considered original observational or interven-
tional studies in adults with ischemic stroke, hemorrhagic
stroke, or TIA reporting prevalence of SDB. The language of
included studies was limited to English, German, French,
Russian, Portuguese, Spanish, and Italian. In case of dis-
agreement about the inclusion of a study, the judgment of
a third reviewer (A.S.) was decisive.
Data extraction
Three reviewers (A.S., L.K., M.C.) independently extracted
data, with differences resolved by consensus. The prespecified
data extraction sheet included demographics, sleep apnea test
characteristics, prevalences of sleep-associated respiratory
events (AHI, respiratory disturbance index, or oxygen desa-
turation index) >5/h, >20/h, and >30/h, and average counts
of AHI, obstructive apnea indices, and central apnea indices.
We decided to use these thresholds because the diagnosis of
SDB in patients with stroke is currently given from an AHI
>5/h,15 whereas therapy in studies is often started with AHI
>20/h, and SDB is considered to be severe (and linked with
increased cardiovascular morbidity) from AHI >30/h.1
The diagnostic sleep apnea tests were classified according to
the American Academy of SleepMedicine as either type I (full
facility-based polysomnography), type II (same channels as
full polysomnographies, but unattended), type III (portable
limited-channel device with 2 respiratory variables, oxygen
saturation, and a cardiac variable), or type IV (portable
limited-channel device with 1 or 2 parameters; use of the
diagnostic mode of an automatic positive airway pressure
system was marked separately).16 If the type of diagnostic
procedure was heterogeneous within one study, the study was
assigned to the group of the technically simpler device to
avoid overestimation of data quality. We further noted the
definition of hypopnea that was used for scoring. In addition,
we extracted the type of cerebrovascular event (TIA, ischemic,
or hemorrhagic stroke), stroke etiology according to the
TOAST (Trial of Org 10172 in Acute Stroke Treatment)
classification,17 stroke localization (supra- and infratentorial),
and latency of the diagnostic study from stroke onset. According
Glossary
AHI = apnea-hypopnea index; CI = confidence interval; SDB = sleep-disordered breathing.
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to the latency, studies were categorized into acute (less than 1
month after stroke), subacute (1–3months), and chronic (more
than 3 months after stroke) phase. Studies for which time of
evaluation had not been precisely declared were classified within
the group most plausible according to the study’s text.
Quality assessment
Because the types of included studies were very heteroge-
neous, no validated tool for the assessment of the study
quality could be applied. Nevertheless, we recorded the ap-
plied criteria for stroke severity, diagnostic criteria of SDB, the
number of patients included from all the patients fulfilling
inclusion criteria, as well as characteristics of the population
such as stroke severity, age, and other inclusion or exclusion
criteria. We further assessed whether sleep apnea tests were
attended or unattended, had a minimum duration and had
been analyzed manually or automatically (accounting for
detection bias), and whether cardiac or pulmonary comor-
bidities and medication, representing possible confounding
factors, had been taken into consideration.
Statistical analysis
We provide a quantitative synthesis of the findings from the
included studies (mean and SD or percent with 95% confi-
dence interval [CI]) by using random-effects meta-analyses to
account for study heterogeneity. When studies did not pro-
vide a mean value (e.g., for AHI), the median was used where
available. Where SD was missing, it was estimated by using
25th and 75th percentiles.18 Average counts and SDs of
individual studies were transformed to CIs before analysis and
transformed back afterward, which resulted in asymmetrical
CIs.19 We assessed between-trial heterogeneity by calculating
the I2 statistic20 as a measure of the proportion of total vari-
ation in estimates that is attributable to heterogeneity, where
I2 values of 25%, 50%, and 75% correspond to low, moderate,
and high degrees of heterogeneity. Publication bias was
assessed using the Egger regression test and funnel plots.21
We used themeta package in R (version 3.3.2; R Foundation for
Statistical Computing, Vienna, Austria) to analyze data.22,23
Data availability
Any data not published within the article are available from
Dryad (appendices, doi.org/10.5061/dryad.n76v191).
Results
Study characteristics
The initial search identified 5,211 publications. After screen-
ing of titles and abstracts, we retrieved 417 articles as full text.
Of these, 86 met our inclusion criteria. Three of the included
studies reported prevalence of SDB longitudinally from 2
different time points after stroke,24–26 which results in a total
of 89 datasets (7,096 patients). The process of identifying
eligible studies is summarized in figure 1. Appendices e-2.1 to e-2.3
(doi.org/10.5061/dryad.n76v191) summarize the characteristics
of included studies. A list of the 330 excluded full texts with
reasons for exclusions is available from the authors on request.
Table PICO table for sleep-disordered breathing after stroke
Population Studies including adults (older than 18 y) with a stroke (ischemic or hemorrhagic) or TIA, diagnosed by qualified personnel (in an
emergency department, stroke center, department of neurology, or similar unit)
Intervention or
exposure
Studies that used diagnostic testing for sleep-disordered breathing (devices with at least 2 channels, one of which is oximetry)
Inclusion criteria
Observational and experimental original studies in human adults
Studies including at least 10 individuals with stroke or TIA, which reported prevalence of sleep-disordered breathing (as AHI, RDI,
or ODI)
Exclusion criteria
Studies not published as full reports (review, meta-analysis, editorial, letter, protocol, unpublished data, conference abstract,
thesis, dissertation, in-press manuscript, case report)
Preselected high-risk populations for sleep-disordered breathing; populations that have already been diagnosed with sleep-
disordered breathing
Additional publications from included trials
Articles in languages other than English, German, Italian, Spanish, Portuguese, French, and Russian
Comparison Not applicable
Outcome Prevalence of sleep disordered breathing: percentage of patients with AHI per hour of >5, >20, or >30
Mean AHI overall
Prevalence and mean AHI according to phase after stroke: acute (<1 mo), subacute (1–3 mo), and chronic (>3 mo) phase
Abbreviations: AHI = apnea-hypopnea index; ODI = oxygen desaturation index; PICO = population, intervention, comparison, outcome; RDI = respiratory
disturbance index.
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Most of the studies were published after the year 2000 and
have been performed in Europe, the United States, or Canada.
Thirteen studies (15%) have been located in Asian countries,
3 (3%) in South America, and 3 (3%) in Australia. Sixty-one
studies (71%) included hospitalized patients, 23 (27%) took
place in a rehabilitation unit, and 2 (2%) recruited patients
from a community-based ambulatory cohort.
A total of 54 studies (61%) have been performed in the acute
phase after stroke (4,545 patients, i.e., 64% of total), 23 (26%)
in the subacute phase (1,993 patients, i.e., 28% of total), and
12 (13%) in the chronic phase (558 patients, i.e., 8% of total).
The earliest time point for assessment of SDB was during the
first night after stroke7,27–29; the latest diagnostic studies have
been performed after a mean of 826 days following stroke.30
Overall, 5,275 patients (74% of total) had an ischemic stroke,
302 (4% of total) had a hemorrhagic stroke, 405 (6% of total)
had a TIA, and for 1,188 patients (16% of total), the type of
the cerebrovascular event was not reported.
In 41 studies (49%), full polysomnography was used as di-
agnostic tool (sleep apnea tests type I or II), 34 studies (39%)
used limited-channel devices (type III), 2 studies (2%) used
limited-channel devices (type IV), and 9 studies (10%) used
the diagnostic mode of an automatic positive airway pressure
device. The definition of hypopnea was variable (data avail-
able from Dryad, appendix e-2, doi.org/10.5061/dryad.
n76v191).
The overall prevalence of SDB with an AHI >5/h was 71%
(95% CI 66.6%–74.8%), 40% for an AHI >20/h (95% CI
33.45%–46.85%), and 30% for an AHI >30/h (95% CI
24.4%–35.5%) with a high between-study heterogeneity.
Prevalences were similar at all 3 analyzed prespecified latencies
from stroke onset (figure 2), but there were generally fewer
studies available for the prevalence of SDB in the chronic phase
after stroke, with a larger range of SD. The overall prevalence of
central sleep apnea (≥50% of total apneas scored as central) with
an AHI >5/h was 12% (95% CI 5.5%–23.4%). There were no
data available to calculate the prevalence of central sleep apnea
with an AHI >20/h or >30/h.
Studies using a hypopnea definition based on desaturation
only did not yield a significantly higher prevalence of AHI >5/h
(70%) or >30/h (29%) than those based on either desaturation
or arousal (60% AHI >5/h, 38% AHI >30/h; p = 0.286 for AHI
>5/h, p = 0.15 for AHI >30/h). Prevalence of AHI >5/h was
significantly higher in studies using a minimal desaturation of 3%
for hypopneas (83%) compared to those using 4% (64%; p =
0.003) but not significantly different for AHI >30/h (45% of
patients when 3% desaturation was used, 54% when 4% desa-
turation was required; p = 0.619). However, both results have to
be interpreted with caution, as they are mainly driven by 2
studies with a small sample size.31,32
Figure 1 Flow diagram of search strategy and study
selection
Last search: April 7, 2017.
Figure 2 Prevalence of AHI >5/h, >20/h, and >30/h for the
acute, subacute, and chronic phase after stroke or
TIA
Prevalence in percentage of all includedpatients across the studieswith 95%
confidence interval. AHI = apnea-hypopnea index; n = number of studies
available.
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The overall mean AHI for all included studies and all time
points was 26.0/h (95%CI 21.7–31.2, n = 44, I2 24%) (figure 3),
the mean obstructive apnea index was 11.7/h (95%CI 6.5–21.1,
n = 12, I2 32%), themean central apnea indexwas 5.3/h (95%CI
2.8–10.0, n = 13, I2 12%), and all the other events were hypo-
pneas, adding up to the overall mean AHI. The analysis of the
different time points showed a mean AHI of 25.0/h (95% CI
20.23–30.9, n = 28, I2 0%) in the acute phase after stroke. There
was a higher mean AHI in the subacute phase (mean AHI 38.9/
h, 95% CI 31.0–48.7, n = 11, I2 3.0%), which was statistically
significant compared to the acute and chronic phase in the
random-effects model (p = 0.017). However, looking at the
forest plot (figure 3) and the relative weight of the studies in
the average effect, there is one study with a small sample size and
a very small SD that has strongly influenced this result.31
The analysis of the different diagnostic tools that were used to
examine the patients revealed a slightly higher mean AHI in
the studies using polysomnography (mean AHI 25.7/h, 95%
CI 17.3–34.2) compared to portable limited-channel devices
(mean AHI 22.9/h, 95% CI 16.9–28.9), but the difference did
not reach statistical significance (p = 0.148).
A summary of the quality assessment of the included studies
can be found in data available fromDryad (appendices e-3 and
e-4, doi.org/10.5061/dryad.n76v191). Almost all studies ex-
cluded patients with severely decreased consciousness or
other severe medical comorbidities. Seven studies had addi-
tional inclusion criteria for maximum severity of strokes.
About half (n = 44) of the studies did not explicitly exclude
patients with known cardiac or lung disease. For their sleep
apnea test, 16 studies required a minimum duration of reg-
istration from 1 to 6 hours. Most of the studies were un-
attended. About half of the sleep apnea tests have at least
partly been manually scored. Seven studies mentioned use of
sedative medication in their exclusion criteria. A few studies
(n = 8) excluded central sleep apnea. We noted funnel plot
asymmetries for the prevalence of AHI >5/h, >20/h, and
>30/h. The Egger test indicated publication bias for the
overall mean AHI (p < 0.001) and for the prevalence of SDB
with an AHI >5/h (p < 0.001) but not for the mean AHI of
studies including only ischemic patients (p = 0.485), the
prevalence of SDB with an AHI >20/h (p = 0.507), and the
prevalence of SDB with an AHI >30/h (p = 0.674).
Discussion
Our large standardized meta-analysis of 89 datasets with
a total of 7,096 patients shows a high prevalence of SDB after
stroke and TIA with 70% of patients having an AHI >5/h and
one-third of patients having severe SDB (AHI >30/h). This
major finding confirms the results of the smaller 2010 published
meta-analysis (29 studies with a total of 2,343 patients).11
The pathophysiologic mechanisms of SDB in patients with
stroke and TIA are still not completely understood. In some
patients, SDB is probably preexisting; changes of upper airway
patency and increased supine positioning poststroke may also
contribute. A recent study in the general population using
a 3% threshold for the definition of hypopnea found an AHI of
more than 5/h in 84% of men and 61% of women, which
equals our results.33 As these authors point out, these per-
centages are, however, higher than those seen in studies using
a 4% threshold.34–37
Figure 3 Forest plot of mean AHI in the acute, subacute,
and chronic phase after stroke
The numbers in the first column refer to the reference numbers in data
available from Dryad (appendix e-5, doi.org/10.5061/dryad.n76v191). Only
studies reporting mean value are included. The horizontal lines and blocks
represent the mean AHI with 95% confidence intervals for each study. The
width of the blocks represents the relative weight of the study in the average
effect. The center of the diamonds is the pooled point estimate of the
studies included for each phase after stroke. The width of the diamonds
represents the 95% confidence interval of the pooled mean value. AHI =
apnea-hypopnea index.
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Although the prevalence of SDB in stroke survivors is high in
our meta-analysis, the following circumstances could have
even led to an underestimation of SDB: first, most of the
analyzed studies were biased toward mildly affected stroke
patients and they explicitly excluded patients with severe
comorbidities, who would be expected to have more risk
factors for SDB than healthier individuals. Second, patients
with known SDB as well as patients with central sleep apnea
have been excluded in many trials. Contrariwise, the potential
confounding effects of sedating medication have not been
considered by most of the studies and could possibly have
increased the AHI in some individuals.38
Mean AHI also remained constantly high from the acute to
the subacute and chronic phase after stroke. The finding of an
even slightly higher mean AHI in the subacute compared to
the acute and chronic phase after stroke could mainly be
attributed to one small study, so that we can assume an almost
constant course. In group comparisons, we could therefore
not confirm a tendency of a decrease of apneas over time,
which has been reported by longitudinal studies.25,26,39,40 This
might be attributable to our cross-sectional study design and
the heterogeneity of the studies in our meta-analysis. A con-
stant prevalence of SDB has been described after TIA but not
after stroke in 2 patient series from the same study
authors.24,25 We could not separately analyze TIA and stroke
patients in our study because of limited data. Concerning the
type of apneic events, we demonstrated a predominance of
obstructive over central apneas in mean AHI, which confirms
previous reports of mainly obstructive sleep apnea after ce-
rebrovascular events and is also in line with recent findings for
the general population.33,41
Comparing the mean AHI yielded by polysomnography
(sleep apnea test type I and II) and limited-channel devices
(sleep apnea test type III and IV), which has resulted in
nonsignificant differences, reinforces the impression that
screening of SDB can be performed in the clinical routine with
respiratory polygraphy, which has proven to be feasible in
previous studies.42,43 Despite this successful use of limited-
channel devices in patients with acute and postacute stroke, it
has to be considered that validation studies against poly-
somnography have been performed in patients with stroke
only for one special acoustic device and otherwise rely on
comparative studies in the general population.1,44
Our results have to be interpreted in the light of the following
limitations: there was a large methodologic and statistical
heterogeneity between the studies. This consists of different
inclusion criteria, different AHI cutoffs, missing reporting of
stroke severity or lesion size in most studies, the application of
variable definitions for hypopnea, and partial use of the oxy-
gen desaturation index instead of AHI. Furthermore, validity
of the reports’ apnea counts are limited by the absence of
minimal duration criteria (as opposed to the recommendation
of the American Academy of Sleep Medicine16) and by the
lack of visual correction of sleep apnea test scoring in several
trials. Moreover, there was statistical evidence for publication
bias. Smaller studies tend to report higher values for AHI and
higher prevalence of mild SDB (AHI >5/h). However, the
funnel plots did not indicate that elimination of these studies
would change our results. External validity is further limited as
most of the studies included were from tertiary care centers
and thus not based on the general population.
A limitation of our method is the statistical approach to
a meta-analysis of average counts, which have been treated as
if they were normally distributed rather than Poisson dis-
tributed. As this was caused by a lack of alternative
approaches, we could not correct for this. In addition, the
assignment of the studies into our chosen phases after stroke
has proved difficult in some cases, particularly when the la-
tency between stroke and sleep apnea test was highly variable
within one study. Furthermore, the use of a statistical test to
compare the AHI for our chosen phases after stroke is chal-
lenging because some individuals may have contributed to
more than one time point.
SDB in patients with stroke is frequent irrespective of the
latency after stroke onset. For clinical routine, limited-channel
devices appear to be promising tools to estimate SDB severity
in this clinical setting. Their use is expected to facilitate and
accelerate the identification of patients with SDB at limited
costs. Recent studies reporting the feasibility and efficacy of
SDB treatment in stroke/TIA justify the recommendation for
a rapid screening of SDB in the stroke unit.12,45,46
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7. Iranzo A, Santamaŕıa J, Berenguer J, Sánchez M, Chamorro A. Prevalence and clinical
importance of sleep apnea in the first night after cerebral infarction. Neurology 2002;
58:911–916.
8. Kaneko Y, Hajek VE, Zivanovic V, Raboud J, Bradley TD. Relationship of sleep apnea to
functional capacity and length of hospitalization following stroke. Sleep 2003;26:293–297.
9. Yan-fang S, Yu-ping W. Sleep-disordered breathing: impact on functional outcome of
ischemic stroke patients. Sleep Med 2009;10:717–719.
10. Aaronson JA, van Bennekom CA, Hofman WF, et al. Obstructive sleep apnea is related to
impaired cognitive and functional status after stroke. Sleep 2015;38:1431–1437.
11. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients:
a meta-analysis. J Clin Sleep Med 2010;6:131–137.
12. Brill AK, Horvath T, Seiler A, et al. CPAP as treatment of sleep apnea after stroke:
a meta-analysis of randomized trials. Neurology 2018;90:e1222–e1230.
13. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in
patients with stroke and transient ischemic attack: a guideline for healthcare pro-
fessionals from the American Heart Association/American Stroke Association. Stroke
2014;45:2160–2236.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic
reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
15. American Academy of SleepMedicine. International Classification of Sleep Disorders,
3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
16. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic
testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine
clinical practice guideline. J Clin Sleep Med 2017;13:479–504.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute
ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org
10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
18. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation
from the sample size, median, range and/or interquartile range. BMC Med Res
Methodol 2014;14:135.
19. Quan H, Zhang J. Estimate of standard deviation for a log-transformed variable using
arithmetic means and standard deviations. Stat Med 2003;22:2723–2736.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med
2002;21:1539–1558.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by
a simple, graphical test. BMJ 1997;315:629–634.
22. R: A Language and Environment for Statistical Computing [computer program].
Vienna: The R Foundation for Statistical Computing; 2011.
23. Schwarzer G. Meta: General Package for Meta-Analysis. R-package version 4.3-0;
2015.
24. Bravata DM, Concato J, Fried T, et al. Auto-titrating continuous positive airway
pressure for patients with acute transient ischemic attack: a randomized feasibility
trial. Stroke 2010;41:1464–1470.
25. Bravata DM, Concato J, Fried T, et al. Continuous positive airway pressure: evaluation
of a novel therapy for patients with acute ischemic stroke. Sleep 2011;34:1271–1277.
26. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in
first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:
375–380.
27. Selic C, Siccoli MM, Hermann DM, Bassetti CL. Blood pressure evolution after acute
ischemic stroke in patients with and without sleep apnea. Stroke 2005;36:2614–2618.
28. Siccoli MM, Valko PO, Hermann DM, Bassetti CL. Central periodic breathing during
sleep in 74 patients with acute ischemic stroke: neurogenic and cardiogenic factors.
J Neurol 2008;255:1687–1692.
29. Pontes-Neto OM, Fernandes RMF, Sander HH, et al. Obstructive sleep apnea is
frequent in patients with hypertensive intracerebral hemorrhage and is related to
perihematoma edema. Cerebrovasc Dis 2010;29:36–42.
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